The Clinical Dispatch
  • Articles
  • About
  • Articles
  • About
  1. Efficacy and Safety of Once-Monthly Brenipatide for Reduction of Relapse in Alcohol Use Disorder: A Phase 2/3 Randomized Controlled Trial
  2. ›
  3. Topic Deep Dives
Topic Deep Dives

Deep Dives 2

In-depth clinical explorations developed alongside this publication.

In this seriesTopic Deep Dives5
  • Clinical Pearl
  • Topic Deep Dives2
  • Manuscript Summary
  • Patient Summary
  • Clinical Checklist
  1. 1

    Treatment

    Efficacy of Brenipatide in Alcohol Use Disorder

    Brenipatide demonstrates significant efficacy in promoting abstinence and reducing cravings in adults with alcohol use disorder.

    8 min read →

  2. 2

    Pathophysiology

    Mechanisms of Brenipatide in Reducing Alcohol Cravings

    Understanding the mechanisms of action for brenipatide can provide insights into its therapeutic benefits for alcohol use disorder.

    6 min read →

In this series

  • Clinical Pearl
  • Topic Deep Dives2
  • Manuscript Summary
  • Patient Summary
  • Clinical Checklist

This content accompanies

Phase 2/3 Clinical Trial

Efficacy and Safety of Once-Monthly Brenipatide for Reduction of Relapse in Alcohol Use Disorder: A Phase 2/3 Randomized Controlled Trial

Journal of Clinical Psychiatry · April 2025

Back to article hub →
The Clinical Dispatch

Published by Endpoint Medical Communications

  • Articles
  • About

© 2026 Endpoint Medical Communications. All rights reserved.

Content on this site is intended for healthcare professionals. AI-assisted summaries have been reviewed by editorial staff.